Product Description
As an anti-tumor medicine, Yitaida can be used for treating acute promyelocytic leukemia (APL) and primary advanced Liver cancer.As a patented medicine and the first of its kind in the world, Yitaida has a particular functional mechanism and is the primar
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Arsenious Acid and Sodium Chloride Injection</strong> is a sterile parenteral solution used primarily in oncology. The core process involves synthesizing arsenic trioxide with sodium chloride for intravenous administration. Molecular formula: AsH3O3·NaCl. CAS No: 10102-48-6 (Arsenic Trioxide).</p>
<h3>Application</h3>
<ul>
<li>Hematologic malignancies, specifically acute promyelocytic leukemia (APL).</li>
<li>Induction and consolidation therapy for relapsed or refractory APL cases.</li>
<li>Supportive care in targeted cancer treatment protocols.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly monitor for QT prolongation and electrolyte imbalances. Requires specialized storage below 25°C away from light. Handling demands PPE due to high toxicity; contraindicated in pregnancy unless benefits outweigh risks.</p>